JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greenberg, S.
Right arrow Articles by Mosle, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greenberg, S.
Right arrow Articles by Mosle, M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 189, Issue 1, 130-139, 1974
Copyright © 1974 by American Society for Pharmacology and Experimental Therapeutics


THE ROLE OF THE AUTONOMIC NERVOUS SYSTEM IN THE RESPONSES OF THE PERFUSED CANINE PAW TO PROSTAGLANDINS B1 AND B2

Stanley Greenberg 1, James A. Engelbrecht 1, William R. Wilson 1, and Marilyn Mosle 1

1 Departments of Internal Medicine and Pharmacology, College of Medicine, University Hospitals, Iowa City, Iowa

The interaction between the autonomic nervous system and prostaglandin B2 (PGB2) and prostaglandin B1 (PGB1)-induced vasoconstriction was evaluated in the normally innervated and acutely denervated canine hindpaw perfused with autologous blood at constant flow. Intra-arterial infusions of PGB2 (50-1600 ng/kg/min) produced concentration-dependent vasoconstriction. Pretreatment of dogs with bretylium (20 mg/kg i.v.), phentolamine (2 mg/kg i.v.), reserpine (0.5 mg/kg/day for 2 days) or acute denervation unmasked a vasodilator component to PGB2 and reduced the magnitude of the constrictor response to this prostaglandin. However, the constrictor response to PGB2 could not be abolished by adrenergic blocking agents. In contrast to these findings, low concentrations of PGB1 (50-200 ng/kg/min) dilated the canine hindpaw whereas higher concentrations (200-3200 ng/kg/min) resulted in cutaneous vasoconstriction. PGB1 is 8 times less potent a vasoconstrictor than PGB2. Bretylium and phentolamine, reserpine and acute denervation also reduced the vasoconstrictor response to PGB1. These findings suggest that 1) PGB2 and PGB1 act directly on smooth muscle to cause both vasodilation and vasoconstriction, 2) a portion of the vasoconstrictor respouse to these prostaglandins is mediated by PGB-induced release of catecholamines from adrenergic nerve terminals and 3) PGB-induced release of catecholamines appears to be dependent on the electrical impulse activity along the sympathetic adrenergic fibers.

Submitted on June 27, 1973
Accepted on November 30, 1973







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics.